Electro-Gene-Transfer: A New Approach for Muscle Gene Delivery

Gene transfer into skeletal muscle cells by direct injection of naked plasmid DNA results in sustained gene expression. Intramuscular injection of plasmid DNA might thus be used to correct myopathies, to secrete locally or systematic therapeutic proteins and to elicit an immune response against specific antigens. However, the potential utility of this technique for gene application in humans is limited by the poor transduction efficiency and the low and highly variable level of gene expression. Different methods are thus being developed to increase the efficiency of gene transfer in muscles. It has been recently reported that a dramatic improvement of DNA transfer is achieved by applying an electric field to the muscle fibers subsequent to local DNA injection. Electro-gene-transfer increases gene expression by several orders of magnitude and strongly reduces interindividual variability. Electroinjection of genes encoding for secreted proteins resulted in sustained expression and disease correction in animal models of gene therapy. Moreover, the immunogenicity of DNA vaccines is dramatically increased when antigen-encoding plasmids are delivered by this technique. This technique may thus have broad and important applications in human gene therapy. This review provides a brief overview of the theory of electro-gene-transfer and describes parameters governing its efficiency in muscle. We also summarize the results obtained with electro-gene-transfer in animal models to date and the technical issues that must be solved before its use for human therapy can be considered.

[1]  A. Benabid,et al.  Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. , 2000, Human gene therapy.

[2]  J. Ulmer,et al.  Enhancement of DNA vaccine potency by electroporation in vivo. , 2000, Journal of biotechnology.

[3]  S. Hoffman,et al.  Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. , 1998, Science.

[4]  T. Kurata,et al.  Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. , 2000, Vaccine.

[5]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[6]  G. Ciliberto,et al.  Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. , 2000, Human gene therapy.

[7]  D. Weiner,et al.  First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. , 1998, The Journal of infectious diseases.

[8]  D. Weiner,et al.  Modulating the immune response to genetic immunization , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Khursheed Anwer,et al.  Polyvinyl Derivatives as Novel Interactive Polymers for Controlled Gene Delivery to Muscle , 1996, Pharmaceutical Research.

[10]  JOHN W. Moore Membranes, ions, and impulses , 1976 .

[11]  A. Folgori,et al.  Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer , 2000, Journal of Virology.

[12]  M. Bureau,et al.  Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. , 2000, Biochimica et biophysica acta.

[13]  J. Miyazaki,et al.  Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. , 2000, Human gene therapy.

[14]  R. Schwartz,et al.  Myogenic expression of an injectable protease-resistant growth hormone–releasing hormone augments long-term growth in pigs , 1999, Nature Biotechnology.

[15]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[16]  R. Schwartz,et al.  Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences , 1999, Nature Biotechnology.

[17]  G. Thorburn,et al.  Chromium-51 Ethylenediaminetetraacetate for Estimation of Glomerular Filtration Rate , 1966, Science.

[18]  Jaroszeski,et al.  In vivo gene delivery by electroporation. , 1999, Advanced drug delivery reviews.

[19]  P Raskmark,et al.  In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. , 1999, Biochimica et biophysica acta.

[20]  G. Nabel,et al.  Direct gene transfer for immunotherapy and immunization. , 1993, Trends in biotechnology.

[21]  P. Usherwood,et al.  Charge and Field Effects in Biosystems―2 , 1990 .

[22]  D. McDonald,et al.  Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice1 , 2000, The Journal of Immunology.

[23]  J. Gehl,et al.  Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. , 1999, Biochemical and biophysical research communications.

[24]  B. O’Malley,et al.  Ligand-dependent regulation of plasmid-based transgene expression in vivo. , 1999, Human gene therapy.

[25]  S. Hoffman,et al.  Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection. , 1999, Human gene therapy.

[26]  E. Sandström,et al.  Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients , 1998, The Lancet.

[27]  P Berg,et al.  Electroporation for the efficient transfection of mammalian cells with DNA. , 1987, Nucleic acids research.

[28]  W. Eaglstein,et al.  Synergistic Effect of Formulated Plasmid and Needle-Free Injection for Genetic Vaccines , 1999, Pharmaceutical Research.

[29]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.

[30]  J. Ulmer,et al.  Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo , 2000, The Journal of Immunology.